Related references
Note: Only part of the references are listed.New developments in immunotherapy for pediatric leukemia
Jessica B. Foster et al.
CURRENT OPINION IN PEDIATRICS (2018)
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial
Norio Shiba et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Factors associated with improved outcomes after second allogeneic hematopoietic cell transplantation for relapsed pediatric leukemia
Neethu N. Menon et al.
ANNALS OF HEMATOLOGY (2016)
Outcomes of Cord Blood Transplantation as Salvage Therapy after Graft Failure or Relapse after Prior Allogeneic Transplantation
Rachel B. Salit et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Cord-Blood Transplantation in Patients with Minimal Residual Disease
Filippo Milano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL
Shannon L. Maude et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Outcome of Allogeneic Hematopoietic Cell Transplantation for Children with FMS-Like Tyrosine Kinase 3 Internal Tandem Duplication-Positive Acute Myelogenous Leukemia
Tal Schechter et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
Shannon L. Maude et al.
BLOOD (2015)
Sorafenib Maintenance Appears Safe and Improves Clinical Outcomes in FLT3-ITD Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation
Ahmad Antar et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Genomics in acute lymphoblastic leukaemia: insights and treatment implications
Kathryn G. Roberts et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Sorafenib Treatment Following Hematopoietic Stem Cell Transplant in Pediatric FLT3/ITD Acute Myeloid Leukemia
Katherine Tarlock et al.
PEDIATRIC BLOOD & CANCER (2015)
Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
Alan S. Gamis et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Initial Experience With CMC-544 (Inotuzumab Ozogamicin) in Pediatric Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Michael Rytting et al.
PEDIATRIC BLOOD & CANCER (2014)
Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project
Mignon L. Loh et al.
BLOOD (2013)
Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies
R. Bajwa et al.
BONE MARROW TRANSPLANTATION (2013)
Outcome modeling with CRLF2, IKZF1, JAK and minimal residual disease Study in pediatric acute lymphoblastic leukemia: a Children's Oncology Group
I. Ming Chen et al.
BLOOD (2012)
Outcome of Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation for Childhood Acute Lymphoblastic Leukemia in Third Remission
Eneida R. Nemecek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Eneida R. Nemecek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Unrelated Donor Bone Marrow Transplantation for Myelodysplastic Syndrome in Children
Paul Woodard et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study
B. Strahm et al.
LEUKEMIA (2011)
Nonmyeloablative Second Transplants are Associated with Lower Nonrelapse Mortality and Superior Survival Than Myeloablative Second Transplants
Brian T. Hill et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study
Georg Mann et al.
BLOOD (2010)
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Jeffrey E. Rubnitz et al.
LANCET ONCOLOGY (2010)
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.
Ted A. Gooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol
Marieke H. van der Linden et al.
BLOOD (2009)
Second hematopoietic stem cell transplantation in myeloid malignancies
Lisa M. Arfons et al.
CURRENT OPINION IN HEMATOLOGY (2009)
Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group
Peter Bader et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant
B. E. Shaw et al.
BONE MARROW TRANSPLANTATION (2008)
Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group
Beverly J. Lange et al.
BLOOD (2008)
Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation
Marco Mielcarek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)
Kirk R. Schultz et al.
BLOOD (2007)
Clinical implications of FLT3 mutations in pediatric AML
Soheil Meshinchi et al.
BLOOD (2006)
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia
JE Sanders et al.
BLOOD (2005)
Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience
U Yusuf et al.
BONE MARROW TRANSPLANTATION (2004)
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant
M Eapen et al.
BONE MARROW TRANSPLANTATION (2004)
Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia
ER Nemecek et al.
BONE MARROW TRANSPLANTATION (2004)
Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia
S Meshinchi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children
AE Woolfrey et al.
BLOOD (2002)
Share Paper
